Neuropathic Pain Drug Market (Painful Diabetic Neuropathy, Postherpetic and Trigeminal Neuralgia) Forecast to 2022 in New Report Available at MarketOptimizer.org

Dallas, Texas (PRWEB) September 26, 2014 With seven promising neuropathic pain (NP) treatments expected to be launched in the coming years, the NP therapeutics market value – covering painful diabetic neuropathy, postherpetic neuralgia and trigeminal neuralgia – is forecast to increase from $ 2.58 billion in 2012 to $ 3.53 billion by 2022, at a […]